Treatment

VS-6766 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
Phase I Trial of Defactinib and VS-6766.
This study is testing two new drugs, Defactinib and VS-6766, for patients with advanced cancers like certain lung, ovarian, womb, and pancreatic cancers. It aims to find the safest dose and see how well the combination works.
For: NSCLC · Low Grade Serous Ovarian Cancer · Endometrioid Carcinoma
United Kingdom